IntegraGen.com

2024-08-22

Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Integragen. Genetic blueprint of complex human diseases, validated markers and therapeutic targets for diagnosis and treatment of schizophrenia, using genome hybrid identity profiling.

Genetic blueprint of complex human diseases, validated markers and therapeutic targets for diagnosis and treatment of schizophrenia, using genome hybrid identity profiling. Based in Evry, France.